Recent Updates
Recently added Catalysts

TRI LOCUM PARTNERS LP

Track TRI LOCUM PARTNERS LP's latest SEC 13F filing: top biotech and life-sciences stock positions, portfolio weights, largest holdings, and quarter-over-quarter changes.
Updated quarterly · Last refreshed Jun 19, 2026
Showing 6 Stocks Out Of 17. Click On The Tickers For More Details
Stock Compnay Name Shares Held Market Value % of Portfolio QoQ Change
UTHR
UTHR
UNITED THERAPEUTICS CORP DEL
70.37 K
41.73 M
5.9
DFTX
DFTX
DEFINIUM THERAPEUTICS INC
369.59 K
6.99 M
1
AXSM
AXSM
AXSOME THERAPEUTICS INC.
62.12 K
10.50 M
1.5
DNTH
DNTH
DIANTHUS THERAPEUTICS INC
145.54 K
12.21 M
1.7
TARS
TARS
TARSUS PHARMACEUTICALS INC
252.59 K
17.72 M
2.5
ARGX
ARGX
ARGENX SE
31.64 K
23.10 M
3.2
API Access

Simple Pricing, Powerful Insights

Full access to Biotech/Pharma investing and trading opportunities.

No hidden fees, powerful insights, tools, and exclusive real time data to maximize your biotech profits.

yearly_arrow
For Visitors

Preview only and discover why serious investors choose our Premium Plan for comprehensive data.

$0.00 / Month

  • Includes 3 day Elite access
For Serious Investor and Traders
Recommended

Your Key to Consistent Profits: Save Big with Our Annual Plan at Just $19.00 per Month

Only $24.00/ Month

  • Searchable FDA Calendar with 1000+ catalysts like clinical readouts and PDUFA
  • Full access to drug pipelines and company health for informed decisions
  • Probability of Approval (PoA) score cards for each asset
  • Download all data in Excel for your models
  • Historical FDA decisions to shape strategic plans
  • Track biotech earnings and critical catalyst events
  • Monitor insider trading and hedge fund holdings for market insights
  • Options flow and strategy modules (screeners and playbooks)
  • Advanced portfolio tools for smart biotech investments
  • Research on 1,100+ companies and clinical trials
  • Real-time market updates, trends, and analysis
  • Live news feed with customizable alerts (tickers, drugs, indications)
  • Exclusive courses on biotech investment basics
Market Value

$ 712.54 M

Holdings

17

Period

Q1 2026

Holdings in Top 20

100 %

QoQ Changes

-7.48 %

Top 20 Holdings